AU Stock MarketDetailed Quotes

Cynata Therapeutics Ltd (CYPOA)

Watchlist
  • 0.010
  • 0.0000.00%
20min DelayTrading Feb 19 14:27 AET
2.37MMarket Cap0.00P/E (Static)

Cynata Therapeutics Ltd (CYPOA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(FY)Jun 30, 2019
(FY)Jun 30, 2018
(FY)Jun 30, 2017
(FY)Jun 30, 2016
(FY)Jun 30, 2015
Total revenue
Cost of revenue
Gross profit
Operating expense
-24.16%12.55M
19.54%16.54M
52.39%13.84M
-13.62%9.08M
4.49%10.51M
64.10%10.06M
-3.18%6.13M
2.44%6.33M
45.07%6.18M
35.38%4.26M
Selling and administrative expenses
-0.83%3.21M
-20.39%3.23M
-9.65%4.06M
52.87%4.49M
-8.60%2.94M
31.05%3.22M
-0.43%2.45M
52.61%2.46M
-12.05%1.62M
-26.27%1.84M
-Selling and marketing expense
43.11%80.67K
-14.55%56.37K
-75.54%65.97K
-42.96%269.65K
-18.68%472.74K
--581.35K
----
----
----
----
-General and administrative expense
-1.61%3.12M
-20.49%3.18M
-5.44%3.99M
71.24%4.22M
-6.37%2.47M
7.36%2.63M
-0.43%2.45M
52.61%2.46M
-12.05%1.62M
-26.27%1.84M
Research and development costs
-29.96%8.68M
40.45%12.39M
133.58%8.82M
--3.78M
----
----
----
-16.42%3.47M
116.43%4.16M
--1.92M
Depreciation amortization depletion
0.27%280.73K
0.00%279.97K
0.00%279.97K
-0.27%279.97K
0.27%280.73K
0.00%279.97K
0.00%279.97K
-0.27%279.97K
-37.33%280.73K
215,258.17%447.95K
-Depreciation and amortization
0.27%280.73K
0.00%279.97K
0.00%279.97K
-0.27%279.97K
0.27%280.73K
0.00%279.97K
0.00%279.97K
-0.27%279.97K
-37.33%280.73K
215,258.17%447.95K
Other operating expenses
-40.54%378.18K
-5.49%636.07K
27.34%672.99K
-92.75%528.51K
11.08%7.29M
93.27%6.56M
2,856.41%3.4M
-12.04%114.9K
129.91%130.62K
-91.35%56.81K
Operating profit
24.16%-12.55M
-19.54%-16.54M
-52.39%-13.84M
13.62%-9.08M
-4.49%-10.51M
-64.10%-10.06M
3.18%-6.13M
-2.44%-6.33M
-45.07%-6.18M
-35.38%-4.26M
Net non-operating interest income (expenses)
18.38%417.71K
444.98%352.87K
-29.85%64.75K
-35.16%92.3K
-45.37%142.35K
82.30%260.55K
51.68%142.93K
-36.19%94.23K
65.37%147.68K
7.99%89.31K
Non-operating interest income
18.38%417.71K
444.98%352.87K
-29.85%64.75K
-35.16%92.3K
-45.37%142.35K
82.30%260.55K
51.68%142.93K
-36.19%94.23K
65.37%147.68K
7.99%89.31K
Other net income (expenses)
24.64%2.38M
-77.04%1.91M
541.41%8.33M
-80.71%1.3M
406.69%6.73M
-6.58%1.33M
-15.60%1.42M
53.96%1.68M
138.12%1.09M
1,734.01%459.57K
Other non-operating income (expenses)
24.64%2.38M
-77.04%1.91M
541.41%8.33M
-80.71%1.3M
406.69%6.73M
-6.58%1.33M
-15.60%1.42M
53.96%1.68M
138.12%1.09M
1,734.01%459.57K
Income before tax
31.75%-9.74M
-162.20%-14.28M
29.19%-5.45M
-111.31%-7.69M
57.05%-3.64M
-85.54%-8.47M
-0.28%-4.57M
7.81%-4.55M
-33.06%-4.94M
-22.12%-3.71M
Income tax
0
0
0
0
0
0
0
0
0
0
Earnings from equity interest net of tax
Net income
31.75%-9.74M
-162.20%-14.28M
29.19%-5.45M
-111.31%-7.69M
57.05%-3.64M
-85.54%-8.47M
-0.28%-4.57M
7.81%-4.55M
-33.06%-4.94M
-22.12%-3.71M
Net income continuous operations
31.75%-9.74M
-162.20%-14.28M
29.19%-5.45M
-111.31%-7.69M
57.05%-3.64M
-85.54%-8.47M
-0.28%-4.57M
7.81%-4.55M
-33.06%-4.94M
-22.12%-3.71M
Noncontrolling interests
Net income attributable to the company
31.75%-9.74M
-162.20%-14.28M
29.19%-5.45M
-111.31%-7.69M
57.05%-3.64M
-85.54%-8.47M
-0.28%-4.57M
7.81%-4.55M
-33.06%-4.94M
-22.12%-3.71M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
31.75%-9.74M
-162.20%-14.28M
29.19%-5.45M
-111.31%-7.69M
57.05%-3.64M
-85.54%-8.47M
-0.28%-4.57M
7.81%-4.55M
-33.06%-4.94M
-22.12%-3.71M
Diluted earnings per share
Basic earnings per share
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(FY)Jun 30, 2019(FY)Jun 30, 2018(FY)Jun 30, 2017(FY)Jun 30, 2016(FY)Jun 30, 2015
Total revenue
Cost of revenue
Gross profit
Operating expense -24.16%12.55M19.54%16.54M52.39%13.84M-13.62%9.08M4.49%10.51M64.10%10.06M-3.18%6.13M2.44%6.33M45.07%6.18M35.38%4.26M
Selling and administrative expenses -0.83%3.21M-20.39%3.23M-9.65%4.06M52.87%4.49M-8.60%2.94M31.05%3.22M-0.43%2.45M52.61%2.46M-12.05%1.62M-26.27%1.84M
-Selling and marketing expense 43.11%80.67K-14.55%56.37K-75.54%65.97K-42.96%269.65K-18.68%472.74K--581.35K----------------
-General and administrative expense -1.61%3.12M-20.49%3.18M-5.44%3.99M71.24%4.22M-6.37%2.47M7.36%2.63M-0.43%2.45M52.61%2.46M-12.05%1.62M-26.27%1.84M
Research and development costs -29.96%8.68M40.45%12.39M133.58%8.82M--3.78M-------------16.42%3.47M116.43%4.16M--1.92M
Depreciation amortization depletion 0.27%280.73K0.00%279.97K0.00%279.97K-0.27%279.97K0.27%280.73K0.00%279.97K0.00%279.97K-0.27%279.97K-37.33%280.73K215,258.17%447.95K
-Depreciation and amortization 0.27%280.73K0.00%279.97K0.00%279.97K-0.27%279.97K0.27%280.73K0.00%279.97K0.00%279.97K-0.27%279.97K-37.33%280.73K215,258.17%447.95K
Other operating expenses -40.54%378.18K-5.49%636.07K27.34%672.99K-92.75%528.51K11.08%7.29M93.27%6.56M2,856.41%3.4M-12.04%114.9K129.91%130.62K-91.35%56.81K
Operating profit 24.16%-12.55M-19.54%-16.54M-52.39%-13.84M13.62%-9.08M-4.49%-10.51M-64.10%-10.06M3.18%-6.13M-2.44%-6.33M-45.07%-6.18M-35.38%-4.26M
Net non-operating interest income (expenses) 18.38%417.71K444.98%352.87K-29.85%64.75K-35.16%92.3K-45.37%142.35K82.30%260.55K51.68%142.93K-36.19%94.23K65.37%147.68K7.99%89.31K
Non-operating interest income 18.38%417.71K444.98%352.87K-29.85%64.75K-35.16%92.3K-45.37%142.35K82.30%260.55K51.68%142.93K-36.19%94.23K65.37%147.68K7.99%89.31K
Other net income (expenses) 24.64%2.38M-77.04%1.91M541.41%8.33M-80.71%1.3M406.69%6.73M-6.58%1.33M-15.60%1.42M53.96%1.68M138.12%1.09M1,734.01%459.57K
Other non-operating income (expenses) 24.64%2.38M-77.04%1.91M541.41%8.33M-80.71%1.3M406.69%6.73M-6.58%1.33M-15.60%1.42M53.96%1.68M138.12%1.09M1,734.01%459.57K
Income before tax 31.75%-9.74M-162.20%-14.28M29.19%-5.45M-111.31%-7.69M57.05%-3.64M-85.54%-8.47M-0.28%-4.57M7.81%-4.55M-33.06%-4.94M-22.12%-3.71M
Income tax 0000000000
Earnings from equity interest net of tax
Net income 31.75%-9.74M-162.20%-14.28M29.19%-5.45M-111.31%-7.69M57.05%-3.64M-85.54%-8.47M-0.28%-4.57M7.81%-4.55M-33.06%-4.94M-22.12%-3.71M
Net income continuous operations 31.75%-9.74M-162.20%-14.28M29.19%-5.45M-111.31%-7.69M57.05%-3.64M-85.54%-8.47M-0.28%-4.57M7.81%-4.55M-33.06%-4.94M-22.12%-3.71M
Noncontrolling interests
Net income attributable to the company 31.75%-9.74M-162.20%-14.28M29.19%-5.45M-111.31%-7.69M57.05%-3.64M-85.54%-8.47M-0.28%-4.57M7.81%-4.55M-33.06%-4.94M-22.12%-3.71M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 31.75%-9.74M-162.20%-14.28M29.19%-5.45M-111.31%-7.69M57.05%-3.64M-85.54%-8.47M-0.28%-4.57M7.81%-4.55M-33.06%-4.94M-22.12%-3.71M
Diluted earnings per share
Basic earnings per share
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More